MADHAVBAUG

The stock has been placed in Enhanced Surveillance Measure (ESM) list ESM - I (34).

Vaidya Sane Ayurved Laboratories Ltd.

NSE: MADHAVBAUG

SME

Sector: Healthcare

Industry Group: Healthcare Equipment & Supplies

Industry: Medical Equipment & Supplies

188.85-1.1 (-0.61%)

7 Aug, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

69.5 / 100

Value Score

57.5 / 100

Price Momentum Score

4.2 / 100

QVM Score

33.6 / 100

Key Metrics

Market Cap

198.54

P/E (TTM)

22.09

P/B

2.27

P/S (TTM)

1.86

EV/EBITDA

11.55

CAPE (5Y)

39.19

ROE (TTM)

11.98

ROCE (TTM)

12.06

ROA (TTM)

9.92

Avg 3Y ROE

9.39

Earnings 3Y CAGR

19.90

Sales 3Y CAGR

2.59

Sales 5Y CAGR

15.38

Debt/Equity

0.03

Consensus TP

Strong Buy %

Promoter Holding

66.34

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Vaidya Sane Ayurved Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 22.09 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -23.64%

What is P/E Ratio?

Median: 28.93

Value 22.09

7.57116.02

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Weak price momentum

Price Momentum score of 4.2 indicates that the stock has weak price momentum. Research has shown that stocks with lower momentum continue to underperform in the near term

What is Price Momentum score?

4.2 / 100

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 39.2 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

39.2 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Vaidya Sane Ayurved Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Vaidya Sane Ayurved Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Vaidya Sane Ayurved Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34
Indian Promoter	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34	66.34
Foreign Promoter	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	0.00	-	-	-	-	-	0.00	-	-	0.21	0.00	0.00
Mutual Funds / UTI	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	0.00	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.21	0.00	0.00
Non-Institution	33.67	33.66	33.68	33.67	33.67	33.66	33.66	33.66	33.66	33.66	33.45	33.66	33.66
Bodies Corporate	0.00	5.96	6.09	6.56	6.89	8.13	8.65	8.06	8.81	9.12	9.07	9.38	9.97
Others (incl. Retail) No. of shareholders	33.67 491	27.70 455	27.59 522	27.11 584	26.78 622	25.53 700	25.01 816	25.60 856	24.85 798	24.54 763	24.38 676	24.28 665	23.69 635

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Vaidya Sane Ayurved Laboratories Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
VINAYAK G KUDVA	06 May 2026	sell	₹ 280.00	1.30 lac	₹ 3.64 cr

Corporate Actions

History of Vaidya Sane Ayurved Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.25/share
Record date: 6th Sep 2023Ex-date: 5th Sep 2023
Announced on: 27th May 2023
Dividend₹ 0.25/share
Record date: 18th Nov 2022Ex-date: 18th Nov 2022
Announced on: 10th Nov 2022

Company Profile

Overview of Vaidya Sane Ayurved Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Vaidya Sane Ayurved Laboratories Limited is an India-based company, which is engaged in research and development in ayurvedic medicines and the sale of ayurvedic medicines and products through its various franchises and own clinics. The Company is also involved in providing ayurved medical professio...

Key personnel

Mr. Narendra Pawar

Chief Financial Officer

Mr. Yogesh Walawalkar

Chief Strategy Officer, Senior Vice President of Marketing

Dr. Gurudatta Amin

Chief Medical Officer

Dr. Rohit Madhav SaneD

Chief Executive Officer, Managing Director, Executive Director

Ms. Vidyut Bipin GhagD

Whole Time Director

Dr. Sushrut R. DambalD

Independent Director

Dr. Mahesh P. KshirsagarD

Independent Director

Mr. Ratnakar Venkappa RaiD

Independent Director

View all

Incorporated on

06 Apr 1999

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

23 Feb 2022

Free Float

Website

https://madhavbaug.org/clinic-hospital-locator/

Phone no.

+917738070019

Address

FL. 5 1047, SHRIRAM BHAWAN, SHUKRAWAR PETH, PUNE PUNE, MAHARASHTRA, INDIA,, , 411002, India

Frequently Asked Questions

What is the current share price of Vaidya Sane Ayurved Laboratories Ltd.?

The current share price of Vaidya Sane Ayurved Laboratories Ltd. is ₹ 188.85 as of 7 Aug 2026.

What is the market capitalisation of Vaidya Sane Ayurved Laboratories Ltd.?

The market capitalisation of Vaidya Sane Ayurved Laboratories Ltd. stands at ₹ 198.54 Cr.

What is the PE ratio of Vaidya Sane Ayurved Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Vaidya Sane Ayurved Laboratories Ltd. is 22.09 as of the latest trailing twelve months data.

What is the ROE and ROCE of Vaidya Sane Ayurved Laboratories Ltd.?

Vaidya Sane Ayurved Laboratories Ltd. has a Return on Equity (ROE) of 11.98% and a Return on Capital Employed (ROCE) of 12.06% as per the latest financial reports.

What is the 52-week high and low of Vaidya Sane Ayurved Laboratories Ltd.?

The 52-week high of Vaidya Sane Ayurved Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Vaidya Sane Ayurved Laboratories Ltd.?

The dividend yield of Vaidya Sane Ayurved Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Vaidya Sane Ayurved Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 23.69% of Vaidya Sane Ayurved Laboratories Ltd. shares.

What sector does Vaidya Sane Ayurved Laboratories Ltd. belong to?

Vaidya Sane Ayurved Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Vaidya Sane Ayurved Laboratories Ltd.?

The beta of Vaidya Sane Ayurved Laboratories Ltd. is 0.73, indicating its price volatility relative to the broader market.

What is the RSI of Vaidya Sane Ayurved Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Vaidya Sane Ayurved Laboratories Ltd. is 45.17, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Vaidya Sane Ayurved Laboratories Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Vaidya Sane Ayurved Laboratories Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Corporate Actions

Company Profile

Stock Analysis